CORZQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CORZQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the three months ended in Mar. 2024, Core Scientific received $51.6 Mil more from issuing new shares than it paid to buy back shares. It received $2.7 Mil from issuing more debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It received $0.0 Mil on other financial activities. In all, Core Scientific earned $54.4 Mil on financial activities for the three months ended in Mar. 2024.
The historical data trend for Core Scientific's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Scientific Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Cash Flow from Financing | 28.69 | 40.72 | 603.53 | 306.15 | -44.65 |
Core Scientific Quarterly Data | ||||||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cash Flow from Financing | Get a 7-Day Free Trial | -1.02 | -9.95 | -15.38 | -18.30 | 54.36 |
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Core Scientific's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing | (A: Dec. 2023 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 0 | + | 0 | + | -44.649 | + | 0 | + | 0 | + | 0 |
= | -44.6 |
Core Scientific's Cash from Financing for the quarter that ended in Mar. 2024 is:
Cash Flow from Financing | (Q: Mar. 2024 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 55.009 | + | -3.39 | + | 2.744 | + | 0 | + | 0 | + | -0 |
= | 54.4 |
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Scientific (OTCPK:CORZQ) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Core Scientific's issuance of stock for the three months ended in Mar. 2024 was $55.0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Core Scientific's repurchase of stock for the three months ended in Mar. 2024 was $-3.4 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Core Scientific's net issuance of debt for the three months ended in Mar. 2024 was $2.7 Mil. Core Scientific received $2.7 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Core Scientific's net issuance of preferred for the three months ended in Mar. 2024 was $0.0 Mil. Core Scientific paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Core Scientific's cash flow for dividends for the three months ended in Mar. 2024 was $0.0 Mil. Core Scientific received $0.0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Core Scientific's other financing for the three months ended in Mar. 2024 was $0.0 Mil. Core Scientific received $0.0 Mil on other financial activities.
Thank you for viewing the detailed overview of Core Scientific's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Adam Taylor Sullivan | officer: President | C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704 |
Darin Feinstein | director, 10 percent owner, officer: Chief Vision Officer | 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004 |
Sterling Denise Marie Brucia | officer: Chief Financial Officer | C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704 |
Matt Minnis | director | 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004 |
Brian Neville | officer: Chief Accounting Officer | C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004 |
Todd M Duchene | officer: EVP, GC and Secretary | 847 GIBRALTAR DR., MILPITAS CA 95035 |
Michael Trzupek | officer: Chief Financial Officer | 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004 |
Stacie Olivares | director | 2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016 |
Jarvis V. Hollingsworth | director | 100 WEST HOUSTON STREET, SAN ANTONIO TX 78205 |
Michael J Levitt | director, officer: Chief Executive Officer | KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067 |
Dr Kneeland Youngblood | director | C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105 |
John P Mcgarrity | officer: General Counsel and Secretary | 321 N. CLARK STREET, CHICAGO IL 60054 |
Sullivan Colleen | director | 420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037 |
Theodore J Brombach | 10 percent owner | 321 N. CLARK STREET, CHICAGO IL 60054 |
Patrick C Eilers | director, 10 percent owner, officer: Chief Executive Officer | THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602 |
From GuruFocus
By PRNewswire PRNewswire • 12-21-2022
By Tiesvg Tiesvg • 12-29-2022
By PRNewswire PRNewswire • 12-22-2022
By Tiesvg Tiesvg • 12-25-2022
By Tiesvg Tiesvg • 12-27-2022
By Stock market mentor Stock market mentor • 01-03-2023
By PRNewswire PRNewswire • 12-29-2022
By PRNewswire PRNewswire • 12-19-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.